T39.95XA
Billable
Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter
T39.95XA is billable and can be used for reimbursement purposes.
AI Search
Analyze diagnoses and doctors notes
Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter
T39.95XA is billable and can be used for reimbursement purposes.